Cargando…
Novel Uses for Lipid-Lowering Agents
Statin use leads to a reduction in the downstream products of the mevalonate pathway. Knowledge of this pathway has led scientists to investigate the role of statins in cancer prevention and treatment. Statins appear to possess a variety of pleiotropic effects, including inhibition of cell prolifera...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226310/ https://www.ncbi.nlm.nih.gov/pubmed/28090367 |
_version_ | 1782493634255388672 |
---|---|
author | May, Megan Brafford Glode, Ashley |
author_facet | May, Megan Brafford Glode, Ashley |
author_sort | May, Megan Brafford |
collection | PubMed |
description | Statin use leads to a reduction in the downstream products of the mevalonate pathway. Knowledge of this pathway has led scientists to investigate the role of statins in cancer prevention and treatment. Statins appear to possess a variety of pleiotropic effects, including inhibition of cell proliferation; enhanced apoptosis; and modulation of inflammation, endothelial function, and angiogenesis. In cancer specifically, experimental studies have found that statins may induce cancer cell apoptosis and inhibit tumor growth, angiogenesis, and metastasis. These mechanisms have steered researchers into evaluating the possible benefit of statins in the prevention and treatment of malignancies. This review will discuss the literature supporting the use of statins to prevent and treat cancer. |
format | Online Article Text |
id | pubmed-5226310 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Harborside Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-52263102017-01-15 Novel Uses for Lipid-Lowering Agents May, Megan Brafford Glode, Ashley J Adv Pract Oncol Review Article Statin use leads to a reduction in the downstream products of the mevalonate pathway. Knowledge of this pathway has led scientists to investigate the role of statins in cancer prevention and treatment. Statins appear to possess a variety of pleiotropic effects, including inhibition of cell proliferation; enhanced apoptosis; and modulation of inflammation, endothelial function, and angiogenesis. In cancer specifically, experimental studies have found that statins may induce cancer cell apoptosis and inhibit tumor growth, angiogenesis, and metastasis. These mechanisms have steered researchers into evaluating the possible benefit of statins in the prevention and treatment of malignancies. This review will discuss the literature supporting the use of statins to prevent and treat cancer. Harborside Press 2016-03 2016-03-01 /pmc/articles/PMC5226310/ /pubmed/28090367 Text en Copyright © 2016, Harborside Press http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited and is for non-commercial purposes. |
spellingShingle | Review Article May, Megan Brafford Glode, Ashley Novel Uses for Lipid-Lowering Agents |
title | Novel Uses for Lipid-Lowering Agents |
title_full | Novel Uses for Lipid-Lowering Agents |
title_fullStr | Novel Uses for Lipid-Lowering Agents |
title_full_unstemmed | Novel Uses for Lipid-Lowering Agents |
title_short | Novel Uses for Lipid-Lowering Agents |
title_sort | novel uses for lipid-lowering agents |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226310/ https://www.ncbi.nlm.nih.gov/pubmed/28090367 |
work_keys_str_mv | AT maymeganbrafford novelusesforlipidloweringagents AT glodeashley novelusesforlipidloweringagents |